JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue71,64437,197--
Cost of Revenue32,82315,6406,3602,240
Gross Profit38,82121,557-6,360-2,240
Operating Expenses
Research Development34,97519,26415,7709,003
Selling General and Administrative23,06116,7598,2664,969
Non Recurring----
Total Operating Expenses90,85951,66330,39616,212
Operating Income or Loss-19,215-14,466-30,396-16,212
Income from Continuing Operations
Total Other Income/Expenses Net2,8087631,8645,696
Earnings Before Interest and Taxes-19,215-14,466-30,396-16,212
Interest Expense----
Income Before Tax-16,407-13,703-28,532-10,516
Income Tax Expense36---
Minority Interest----
Net Income From Continuing Ops-16,443-13,703-28,532-10,516
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,443-13,703-28,532-10,516
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-17,237-23,138-37,503-12,950